Navigation Links
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
Date:5/10/2013

PARSIPPANY, N.J., May 10, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a global specialty pharmaceutical leader, today confirmed that Actavis has entered into early stage discussions with Warner Chilcott plc (Nasdaq: WCRX) regarding a potential combination of the two companies.  Actavis further stated that no agreement has been reached and it does not intend to issue further comment regarding its business development initiatives. 

About Actavis, Inc.Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

For press release and other company information, visit Actavis' Web site at http://www.actavis.com.

Forward-Looking Statement Statements contained in this press release that refer to Actavis' estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Actavis' current perspective of existing trends and information as of the date of this release. For instance, any statements in this press release concerning prospects related to Actavis' strategic initiatives, including a potential transaction with Warner Chilcott plc, are forward-looking statements. It is important to note that Actavis' goals and expectations are not predictions of actual performance. Actavis' performance, at times, will differ from its goals and expectations
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
2. Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
3. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
4. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
5. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
6. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
7. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
8. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
9. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
10. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
11. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
(Date:4/22/2014)... to trauma, illness, alcohol or other drug abuse, these ... cells that can go awry and activate conditions such ... autism. , Until now, it has been unclear how ... developing brain. Past studies have shown that when an ... or she experiences some trauma or illness, her baby ...
(Date:4/22/2014)... chronic inflammatory disorders of the intestine that result in ... in the U.S., and while there are treatments to ... , Now, Cincinnati Cancer Center and University of Cincinnati ... in her lab have done what is believed to ... important function for the Ron receptor, a cell surface ...
(Date:4/22/2014)... 2014) Older parents are more likely to have ... than are younger parents. A recent study from researchers ... Philadelphia and Karolinska Institute in Sweden provides more insight ... between mothers, and fathers, ages, and found that the ... intellectual disability is larger for older parents., In the ...
(Date:4/22/2014)... NH, 4/22/14). Dartmouth researchers have found that the ... and does not negatively impact a woman,s overall ... False-Positive Screening Mammograms," which was published online in ... , Anywhere from 40 to 60 percent ... a ten-year period will experience a false-positive mammogram. ...
(Date:4/22/2014)... New research published today out of the University of ... promote growth in damaged nerve cells as a means ... his team have discovered a key molecule that directly ... His study was published in the prestigious journal ... and Anand Krishnan. , "We made the surprising ...
Breaking Medicine News(10 mins):Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Two genes linked to inflammatory bowel disease 2Health News:Child's autism risk accelerates with mother's age over 30 2Health News:Child's autism risk accelerates with mother's age over 30 3Health News:False-positive mammogram anxiety has limited impact on women's well-being 2Health News:Scientists discover a new way to enhance nerve growth following injury 2
... loss of the four sick public sector pharmaceutical and ... the railways and the armed forces have been asked ... making units. ,According to the ministry of ... Pharmaceuticals Limited, Hindustan Insecticides Limited and Hindustan Organic Chemicals ...
... have developed a new electro-chemical biosensor, which detects the ... the most widely used herbicides in agriculture and ... environment as well as antibiotics in food. ... the expensive laboratory methods, which are used to detect ...
... Recent studies have indicated that the protein known as ... levels of TRPM8 have been found in prostate ... has been suggested as a specific marker and therapeutic ... changes in TRPM8 during prostate cancer progression have remained ...
... of people made a beeline for guru Ramdev's six-day yoga ... has been specially prepared on the outskirts of this popular ... ,Organisers said some 10,000 people, including Himachal Pradesh ... ,The state transport department has made special arrangements to ...
... has given a green signal for plantation of rise ... in Kansas. ,This is the first ... human proteins will be grown on a large-scale. ... California, the rice strains produce lysozyme, lactoferrin, and human ...
... found that full brain development in adolescents takes place between ... National Institutes of Health (NIH) MRI Study of Normal Brain ... and behaviour from birth to young adulthood. ,The ... of Psychiatry at Childrens Hospital Boston, focused on cognition and ...
Cached Medicine News:Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2Health News:New Electro-chemical Biosensor to Check Food Contamination 2Health News:Adolescents Brains Fully Develop Between 10-12 Years 2
Lorgnette pinhole occluder...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Medicine Products: